REG - Medpal AI PLC - Operational Efficiency Gains in Pharmacy

Medpal AIAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260122:nRSV8655Pa&default-theme=true

RNS Number : 8655P  Medpal AI PLC  22 January 2026

22 January 2026

MedPal AI plc

("MedPal AI" or the "Company")

Significant Operational Efficiency Gains in Pharmacy Subsidiary

MedPal AI plc (AIM: MPAL), the digital health and AI company, is pleased to
announce that, following recent technology infrastructure upgrades, it has
achieved a substantial improvement in dispensing efficiency within its wholly
owned subsidiary MedPal Limited.

Operational Highlights

• 30-fold increase in dispensing efficiency achieved through server
technology updates and upgrades; previously it took an hour to process 40
prescriptions, but with the update in place, the Robopharma robot is capable
of processing more than 100 prescriptions in less than 5 minutes

• Enhanced capacity supports continued growth in pharmacy operations across
NHS contracts and retail services

• Investment reinforces the Company's commitment to scalable,
technology-driven healthcare delivery

The significant efficiency improvement has been realised through comprehensive
server infrastructure modernisation within MedPal Limited, the Company's
pharmacy operating subsidiary. This enhancement directly supports the
Company's robotic dispensing capabilities and integrated pharmacy management
systems.

Jason Drummond, CEO of MedPal AI plc, commented:

"This 30x improvement in dispensing efficiency demonstrates the operational
leverage inherent in our pharmacy infrastructure. By investing strategically
in server technology, we have dramatically enhanced our capacity to serve
patients across our NHS contracts and retail pharmacy services. This upgrade
positions MedPal Limited to handle significantly increased prescription
volumes while maintaining the quality and reliability our customers expect.

"The technology upgrade supports the Company's broader strategy of integrating
AI-powered healthcare services with regulated pharmacy operations, enabling
efficient scaling across its care home and retail pharmacy divisions."

Enquiries:

 MedPal AI plc

 Jason Drummond, Chief Executive Officer     Via Square1 Consulting

 Cairn Financial Advisers LLP                +44 (0) 20 7213 0880

 Louise O'Driscoll/Jo Turner

 Clear Capital Markets Limited               +44 (0) 20 3869 6080

 Bob Roberts

 Square1 Consulting                          +44 (0) 20 7929 5599

 David Bick                                  +44 (0) 7831 381201

 

 

 

About MedPal AI

MedPal AI is a UK-based digital health company specialising in AI-driven
wellness management. Its core app aggregates data from over 100 wearables and
health apps (e.g. Apple Health, Fitbit, Garmin) into a unified profile,
offering non-clinical, personalised lifestyle guidance through its AI wellness
coach. The Company is also developing conversational AI to provide
voice-based, real-time health insights, alerts, and recommendations.

Through its wholly owned subsidiary MedPal Limited, the Company operates a
24/7 AI-powered automated pharmacy distribution centre, providing nationwide
NHS and private prescription services. The facility leverages advanced robotic
dispensing technology integrated with AI triage to deliver rapid,
cost-effective medication fulfilment with same-day and next-day delivery
capabilities.

MedPal AI has a partnership agreement with Epassi UK Limited, which will, for
a limited time, grant exclusive, zero-cost access to the MedPal AI app across
Epassi's network of 11M+ employees at major firms like Siemens and Volvo.
Beyond consumers, MedPal AI plans to expand via B2B licensing to healthcare
providers, businesses, and insurers, with potential use in insurance-linked
wellness programs to reduce premiums and drive new revenue through
institutional partnerships. The Company also has a partnership agreement with
Independent Gyms Ltd.

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or
anticipated future events and anticipated results that are forward-looking in
nature and, as a result, are subject to certain risks and uncertainties, such
as general economic, market and business conditions, competition for qualified
staff, the regulatory process and actions, technical issues, new legislation,
uncertainties resulting from potential delays or changes in plans,
uncertainties resulting from working in a new political jurisdiction,
uncertainties regarding the results of exploration, uncertainties regarding
the timing and granting of prospecting rights, uncertainties regarding the
timing and granting of regulatory and other third party consents and
approvals, uncertainties regarding the Company's or any third party's ability
to execute and implement future plans, and the occurrence of unexpected
events.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRSEFEEFEMSEEF



            Copyright 2019 Regulatory News Service, all rights reserved